Study That Evaluates the Effect of CYP3A4 Inhibition on Lu AG06466 in Healthy Men and Women
Status:
Completed
Trial end date:
2020-07-28
Target enrollment:
Participant gender:
Summary
A study to learn how a drug (itraconazole) that is known to inhibit a certain enzym in the
liver, impacts the body's ability to breakdown Lu AG06466 into breakdown products in healthy
men and women. The main breakdown product is Lu AG06988.